APA (7th ed.) Citation

P, S., A, B., P, V., M, B., G, R., C, P., . . . B, L. (2000). Dose-finding study of valspodar (PSC 833) with daunorubicin and cytarabine to reverse multidrug resistance in elderly patients with previously untreated acute myeloid leukemia. The hematology journal : the official journal of the European Haematology Association, 1(6), 411. https://doi.org/10.1038/sj.thj.6200050

Chicago Style (17th ed.) Citation

P, Sonneveld, et al. "Dose-finding Study of Valspodar (PSC 833) with Daunorubicin and Cytarabine to Reverse Multidrug Resistance in Elderly Patients with Previously Untreated Acute Myeloid Leukemia." The Hematology Journal : The Official Journal of the European Haematology Association 1, no. 6 (2000): 411. https://doi.org/10.1038/sj.thj.6200050.

MLA (9th ed.) Citation

P, Sonneveld, et al. "Dose-finding Study of Valspodar (PSC 833) with Daunorubicin and Cytarabine to Reverse Multidrug Resistance in Elderly Patients with Previously Untreated Acute Myeloid Leukemia." The Hematology Journal : The Official Journal of the European Haematology Association, vol. 1, no. 6, 2000, p. 411, https://doi.org/10.1038/sj.thj.6200050.